Abstract
Approximately one third of the human breast tumors are estradiol (E2)-dependent in the initial stages of the disease. E2 is thought to stimulate growth indirectly, through induced production of autocrine polypeptide growth factors. In this hypothesis constitutive production of such growth factors would lead to the loss of E2 dependence, as associated with progression of the disease. Recent data, however, suggest that breast cancer cells do not react to the growth factors that they produce. Here we provide evidence that the direct stimulation of the c-fos proto-oncogene may be an important step in the stimulation by E2 of the human breast cancer cell line MCF7. E2 by itself, however, is poorly mitogenic, and it does not induce genes from the jun family, whose gene products are necessary for heterodimerization with the c-fos-encoded protein (Fos), leading to an important step in growth factor signalling pathways, stimulation of TPA-responsive element (TRE)-dependent transcriptional activity. In combination with insulin-like growth factors, that were found to be efficient inducers of c-jun in breast cancer cells, E2 synergistically stimulates TRE activity and proliferation. These effects of E2 on growth factor signalling pathways ...Continue Reading
Citations
Feb 1, 1993·Molecular and Cellular Endocrinology·B van der BurgP T van der Saag
Aug 11, 1995·Molecular and Cellular Endocrinology·B van der BurgP T van der Saag
Mar 25, 1996·Molecular and Cellular Endocrinology·M Huber, R Poulin
Jan 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·B van der BurgS W de Laat
Sep 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·B van der BurgS W de Laat
Jun 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·B van der BurgS W de Laat
Mar 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·R L SutherlandE A Musgrove
Mar 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·T ThorsenA Aakvaag
Mar 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·T OjasooJ P Raynaud
Jun 8, 2002·Biochemical and Biophysical Research Communications·Renqin DuanStephen Safe
Jan 5, 2000·Molecular and Cellular Endocrinology·C M KlingeH I Swanson
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I NicholsonR W Blamey
Sep 6, 2008·Journal of Molecular Endocrinology·Stephen Safe, Kyounghyun Kim
Jan 1, 1994·Breast Cancer Research and Treatment·H NaundorfS Reinecke
Mar 23, 2002·The American Journal of the Medical Sciences·K GuptaA N Peiris
Nov 16, 1992·Biochemical and Biophysical Research Communications·K WosikowskiH Mueller
Jan 27, 1995·The Journal of Biological Chemistry·M LessardR Poulin
Apr 20, 2004·The Journal of Biological Chemistry·Marcello MaggioliniSebastiano Andò
May 1, 1994·Circulation·R H KarasM E Mendelsohn
Apr 7, 1998·Endocrinology·R DuanS Safe
Jan 1, 1995·Acta Oncologica·D L ManningC J Ormandy
Aug 22, 2017·Frontiers in Endocrinology·Carsten Gründker, Günter Emons
Jan 19, 2001·The Journal of Biological Chemistry·R DuanS Safe
Oct 20, 1995·The Journal of Biological Chemistry·M B MartinM Saceda
Oct 22, 2005·Molecular Endocrinology·Adele VivacquaMarcello Maggiolini
Feb 12, 1998·Molecular Endocrinology·I ErenburgL Ossowski
Sep 9, 1999·Molecular Endocrinology·R DuanS Safe
Feb 22, 2001·American Journal of Physiology. Renal Physiology·R K Dubey, E K Jackson
Mar 7, 2021·Cells·Carsten Gründker, Günter Emons
Sep 1, 1991·Molecular and Cellular Endocrinology·C V MobbsD W Pfaff
Jul 1, 1994·Molecular and Cellular Biology·K Yamauchi, J E Pessin